ZNTL SCHEDULE 13G/A: SEC filing
An institutional investor
Filed with the SEC on · accession 0001213900-26-091824
ZNTL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 19, 2026. An institutional investor filed an amended Schedule 13G disclosing its beneficial ownership position in Zentalis Pharmaceuticals (ZNTL). The stock moved +3.8% by the first close after the filing.
Summary of the filing
An institutional investor filed an amended Schedule 13G disclosing its beneficial ownership position in Zentalis Pharmaceuticals (ZNTL). The filing indicates a passive investment stake with no stated intent to influence company control.
Key details
How ZNTL stock reacted
Close before
$3.68
Aug 18, 2026
First close after
+3.80%
$3.82
5 trading days
+5.43%
$3.88
Since filing
-53.26%
$1.72
✦ Ask GOAX AI about this filing — what it means for ZNTL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZNTL?
Click hereFrequently asked questions
What did ZNTL file with the SEC on Aug 19, 2026?
ZNTL filed a SCHEDULE 13G/A (SEC filing). An institutional investor filed an amended Schedule 13G disclosing its beneficial ownership position in Zentalis Pharmaceuticals (ZNTL). The filing indicates a passive investment stake with no stated intent to influence company control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ZNTL stock react to this filing?
ZNTL closed at $3.68 before the filing and $3.82 on Aug 19, 2026 (+3.80%). Five trading days later: $3.88 (+5.43%).
Other ZNTL SEC filings
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 8-K · Secondary offeringAug 14, 2026
- 424B5 · Secondary offeringAug 14, 2026
- 424B5 · Secondary offeringAug 13, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingJun 18, 2026
- 8-K · SEC filingMay 27, 2026
- 8-K · Fda approvalMay 21, 2026
Get alerts when ZNTL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days